LLY

1,021.52

+0.37%↑

JNJ

195.34

+0.5%↑

ABBV

232.46

-0.34%↓

UNH

332.18

-2.03%↓

AZN

88.54

+0.99%↑

LLY

1,021.52

+0.37%↑

JNJ

195.34

+0.5%↑

ABBV

232.46

-0.34%↓

UNH

332.18

-2.03%↓

AZN

88.54

+0.99%↑

LLY

1,021.52

+0.37%↑

JNJ

195.34

+0.5%↑

ABBV

232.46

-0.34%↓

UNH

332.18

-2.03%↓

AZN

88.54

+0.99%↑

LLY

1,021.52

+0.37%↑

JNJ

195.34

+0.5%↑

ABBV

232.46

-0.34%↓

UNH

332.18

-2.03%↓

AZN

88.54

+0.99%↑

LLY

1,021.52

+0.37%↑

JNJ

195.34

+0.5%↑

ABBV

232.46

-0.34%↓

UNH

332.18

-2.03%↓

AZN

88.54

+0.99%↑

Search

Globus Medical Inc (Class A)

Cerrado

SectorSalud

83.77 -0.78

Resumen

Variación precio

24h

Actual

Mínimo

83.4

Máximo

85.77

Métricas clave

By Trading Economics

Ingresos

-84M

119M

Ventas

24M

769M

P/B

Media del Sector

27.948

105.69

BPA

1.18

Margen de beneficio

15.469

Empleados

5,300

EBITDA

22M

215M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+7.3% upside

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

3.3B

12B

Apertura anterior

84.55

Cierre anterior

83.77

Noticias sobre sentimiento de mercado

By Acuity

67%

33%

328 / 374 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

Globus Medical Inc (Class A) Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

13 nov 2025, 21:34 UTC

Ganancias

Applied Materials 4Q Sales Fall; Forecasts Higher Demand in 2H26

13 nov 2025, 23:45 UTC

Charlas de Mercado

Nikkei May Fall After Wall Street's Weakness -- Market Talk

13 nov 2025, 23:42 UTC

Adquisiciones, fusiones, absorciones

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 4th Update

13 nov 2025, 23:41 UTC

Charlas de Mercado

Gold Edges Higher on Possible Dip-Buying -- Market Talk

13 nov 2025, 23:24 UTC

Ganancias

JBS NV: Robust U.S. Beef Demand Supported 3Q North America Sales >JBS

13 nov 2025, 23:24 UTC

Ganancias

JBS NV: Live Cattle Prices Have Remained High, Pressuring Profitability >JBS

13 nov 2025, 23:23 UTC

Ganancias

JBS NV 3Q EPS 52c >JBS

13 nov 2025, 23:23 UTC

Ganancias

JBS NV 3Q Sales $22.6B >JBS

13 nov 2025, 23:04 UTC

Charlas de Mercado

RBA Looks Set To Remain Sidelined For a While Yet -- Market Talk

13 nov 2025, 22:02 UTC

Ganancias

Nu Holdings 3Q Net $783M >NU

13 nov 2025, 22:01 UTC

Ganancias

Nu Holdings 3Q Rev $4.2B >NU

13 nov 2025, 21:51 UTC

Adquisiciones, fusiones, absorciones

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 3rd Update

13 nov 2025, 21:50 UTC

Ganancias

Disney Posts Roughly Flat Quarterly Revenue as TV Declines Continue -- 4th Update

13 nov 2025, 21:45 UTC

Adquisiciones, fusiones, absorciones

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 2nd Update

13 nov 2025, 21:41 UTC

Adquisiciones, fusiones, absorciones

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- Update

13 nov 2025, 21:36 UTC

Adquisiciones, fusiones, absorciones

Paramount Plans to Bid for All of Warner Bros., Sources Say -- WSJ

13 nov 2025, 21:36 UTC

Adquisiciones, fusiones, absorciones

Paramount, Comcast, Netflix Among Potential Bidders That Have Looked at Warner Bros. Financials, Sources Say -- WSJ

13 nov 2025, 21:36 UTC

Adquisiciones, fusiones, absorciones

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- WSJ

13 nov 2025, 21:36 UTC

Adquisiciones, fusiones, absorciones

Netflix, Comcast Each Considering Pursuing Warner Bros. Studio, Streaming Assets, Sources Say -- WSJ

13 nov 2025, 21:36 UTC

Adquisiciones, fusiones, absorciones

Bids for Warner Bros. Discovery Due Next Week, Sources Say -- WSJ

13 nov 2025, 21:33 UTC

Charlas de Mercado

Banks See CAD Appreciation Through 2026, Trade Poses 'Clear' Risk -- Market Talk

13 nov 2025, 21:33 UTC

Ganancias

If Investors Like Rocket Lab Stock, They Should Love Firefly Shares -- Barrons.com

13 nov 2025, 21:31 UTC

Ganancias

Applied Materials Stock Falls Despite Strong Earnings -- Barrons.com

13 nov 2025, 21:25 UTC

Ganancias

Figure Tech Solutions 3Q Rev $156.4M >FIGR

13 nov 2025, 21:25 UTC

Ganancias

Figure Tech Solutions 3Q EPS 34c >FIGR

13 nov 2025, 21:23 UTC

Ganancias

Intchains Group 3Q Rev $1.3M >ICG

13 nov 2025, 21:03 UTC

Ganancias

Applied Materials Sees 1Q Rev $6.35B-$7.35B >AMAT

13 nov 2025, 21:02 UTC

Ganancias

Applied Materials Sees 1Q Adj EPS $1.98-Adj EPS $2.38 >AMAT

13 nov 2025, 21:01 UTC

Ganancias

Applied Materials 4Q Rev $6.8B >AMAT

13 nov 2025, 21:01 UTC

Ganancias

Applied Materials 4Q Gross Margin 48.0% >AMAT

Comparación entre iguales

Cambio de precio

Globus Medical Inc (Class A) Esperado

Precio Objetivo

By TipRanks

7.3% repunte

Estimación a 12 meses

Media 90.89 USD  7.3%

Máximo 114 USD

Mínimo 64 USD

De acuerdo con 12 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Globus Medical Inc (Class A) Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

12 ratings

8

Comprar

4

Mantener

0

Vender

Puntuación técnica

By Trading Central

72.18 / 73.07Soporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Bearish Evidence

Largo Plazo

Weak Bearish Evidence

Sentimiento

By Acuity

328 / 374 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura bajista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Globus Medical Inc (Class A)

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
help-icon Live chat